FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387610418> ?p ?o ?g. }

• W4387610418 endingPage "711" @default.
• W4387610418 startingPage "701" @default.
• W4387610418 abstract "To assess the benefits and harms of lipid-lowering therapies used to prevent or manage cardiovascular disease including bile acid sequestrants (BAS), ezetimibe, fibrates, niacin, omega-3 supplements, proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors, and statins.MEDLINE, the Cochrane Database of Systematic Reviews, and a grey literature search.Systematic reviews of randomized controlled trials published between January 2017 and March 2022 looking at statins, ezetimibe, PCSK9 inhibitors, fibrates, BAS, niacin, and omega-3 supplements for preventing cardiovascular outcomes were selected. Outcomes of interest included major adverse cardiovascular events (MACE), cardiovascular mortality, all-cause mortality, and adverse events.A total of 76 systematic reviews were included. Four randomized controlled trials were also included for BAS because no efficacy systematic review was identified. Statins significantly reduced MACE (6 systematic reviews; median risk ratio [RR]=0.74; interquartile range [IQR]=0.71 to 0.76), cardiovascular mortality (7 systematic reviews; median RR=0.85, IQR=0.83 to 0.86), and all-cause mortality (8 systematic reviews; median RR=0.91, IQR=0.88 to 0.92). Major adverse cardiovascular events were also significantly reduced by ezetimibe (3 systematic reviews; median RR=0.93, IQR=0.93 to 0.94), PCSK9 inhibitors (14 systematic reviews; median RR=0.84, IQR=0.83 to 0.87), and fibrates (2 systematic reviews; mean RR=0.86), but these interventions had no effect on cardiovascular or all-cause mortality. Fibrates had no effect on any cardiovascular outcomes when added to a statin. Omega-3 combination supplements had no effect on MACE or all-cause mortality but significantly reduced cardiovascular mortality (5 systematic reviews; median RR=0.93, IQR=0.93 to 0.94). Eicosapentaenoic acid ethyl ester alone significantly reduced MACE (1 systematic review, RR=0.78) and cardiovascular mortality (2 systematic reviews; RRs of 0.82 and 0.82). In primary cardiovascular prevention, only statins showed consistent benefits on MACE (6 systematic reviews; median RR=0.75, IQR=0.73 to 0.78), cardiovascularall-cause mortality (7 systematic reviews, median RR=0.83, IQR=0.81 to 0.90), and all-cause mortality (8 systematic reviews; median RR=0.91, IQR=0.87 to 0.91).Statins have the most consistent evidence for the prevention of cardiovascular complications with a relative risk reduction of about 25% for MACE and 10% to 15% for mortality. The addition of ezetimibe, a PCSK9 inhibitor, or eicosapentaenoic acid ethyl ester to a statin provides additional MACE risk reduction but has no effect on all-cause mortality." @default.
• W4387610418 created "2023-10-14" @default.
• W4387610418 creator A5004004813 @default.
• W4387610418 creator A5006065055 @default.
• W4387610418 creator A5010670355 @default.
• W4387610418 creator A5016418950 @default.
• W4387610418 creator A5018081896 @default.
• W4387610418 creator A5022818995 @default.
• W4387610418 creator A5023434277 @default.
• W4387610418 creator A5029493380 @default.
• W4387610418 creator A5030810577 @default.
• W4387610418 creator A5037611650 @default.
• W4387610418 creator A5042041339 @default.
• W4387610418 creator A5042539932 @default.
• W4387610418 creator A5051560643 @default.
• W4387610418 creator A5060212629 @default.
• W4387610418 creator A5067485672 @default.
• W4387610418 creator A5071894327 @default.
• W4387610418 creator A5072205189 @default.
• W4387610418 creator A5086924606 @default.
• W4387610418 creator A5091301253 @default.
• W4387610418 date "2023-10-01" @default.
• W4387610418 modified "2023-10-18" @default.
• W4387610418 title "Lipid-lowering therapies for cardiovascular disease prevention and management in primary care" @default.
• W4387610418 cites W1520609538 @default.
• W4387610418 cites W1560696636 @default.
• W4387610418 cites W1714980748 @default.
• W4387610418 cites W1816597323 @default.
• W4387610418 cites W1856460279 @default.
• W4387610418 cites W1918267826 @default.
• W4387610418 cites W1993181745 @default.
• W4387610418 cites W2053235682 @default.
• W4387610418 cites W2073644162 @default.
• W4387610418 cites W2098923148 @default.
• W4387610418 cites W2103043503 @default.
• W4387610418 cites W2112007536 @default.
• W4387610418 cites W2120307638 @default.
• W4387610418 cites W2120986848 @default.
• W4387610418 cites W2132942256 @default.
• W4387610418 cites W2134777998 @default.
• W4387610418 cites W2135400982 @default.
• W4387610418 cites W2142347023 @default.
• W4387610418 cites W2156098321 @default.
• W4387610418 cites W2163778695 @default.
• W4387610418 cites W2172860077 @default.
• W4387610418 cites W246286872 @default.
• W4387610418 cites W2485118186 @default.
• W4387610418 cites W2535265582 @default.
• W4387610418 cites W2569797875 @default.
• W4387610418 cites W2581033595 @default.
• W4387610418 cites W2588681363 @default.
• W4387610418 cites W2595484157 @default.
• W4387610418 cites W2596179513 @default.
• W4387610418 cites W2624688719 @default.
• W4387610418 cites W2752541833 @default.
• W4387610418 cites W2758885961 @default.
• W4387610418 cites W2760453366 @default.
• W4387610418 cites W2764097725 @default.
• W4387610418 cites W2766784925 @default.
• W4387610418 cites W2767669362 @default.
• W4387610418 cites W2773258653 @default.
• W4387610418 cites W2778116940 @default.
• W4387610418 cites W2783451247 @default.
• W4387610418 cites W2785975902 @default.
• W4387610418 cites W2802099381 @default.
• W4387610418 cites W2899669642 @default.
• W4387610418 cites W2899997727 @default.
• W4387610418 cites W2902436102 @default.
• W4387610418 cites W2904161276 @default.
• W4387610418 cites W2905047802 @default.
• W4387610418 cites W2909436318 @default.
• W4387610418 cites W2911962097 @default.
• W4387610418 cites W2912253656 @default.
• W4387610418 cites W2914588136 @default.
• W4387610418 cites W2917267661 @default.
• W4387610418 cites W2919911433 @default.
• W4387610418 cites W2921012991 @default.
• W4387610418 cites W2922829459 @default.
• W4387610418 cites W2923031601 @default.
• W4387610418 cites W2924937678 @default.
• W4387610418 cites W2925214501 @default.
• W4387610418 cites W2927934695 @default.
• W4387610418 cites W2939435551 @default.
• W4387610418 cites W2944043838 @default.
• W4387610418 cites W2946529573 @default.
• W4387610418 cites W2953269061 @default.
• W4387610418 cites W2955200437 @default.
• W4387610418 cites W2965466023 @default.
• W4387610418 cites W2971786110 @default.
• W4387610418 cites W2972028269 @default.
• W4387610418 cites W2973595439 @default.
• W4387610418 cites W2976451193 @default.
• W4387610418 cites W2976844203 @default.
• W4387610418 cites W2999915237 @default.
• W4387610418 cites W3006730350 @default.
• W4387610418 cites W3033404795 @default.
• W4387610418 cites W3034605096 @default.
• W4387610418 cites W3039041541 @default.

• next